Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H20N2O2 |
Molecular Weight | 320.385 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)=CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=RBBWCVQDXDFISW-UHFFFAOYSA-N
InChI=1S/C20H20N2O2/c1-15(2)13-14-18-19(23)21(16-9-5-3-6-10-16)22(20(18)24)17-11-7-4-8-12-17/h3-13,18H,14H2,1-2H3
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/1094965Curator's Comment: description was created based on several sources, including, https://www.jstage.jst.go.jp/article/cpb1958/34/1/34_1_214/_pdf
Sources: http://www.ncbi.nlm.nih.gov/pubmed/1094965
Curator's Comment: description was created based on several sources, including, https://www.jstage.jst.go.jp/article/cpb1958/34/1/34_1_214/_pdf
Feprazone is an anti-inflammatory compound developed for the treatment of such conditions as osteoarthritis, rheumatoid arthritis, rheumatic fever and gouty arthritis. The drug was tested in phase III of clinical trials, however its further faith is unknown.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/1094965
150 mg four times daily.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
M01AX18
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
||
|
NCI_THESAURUS |
C1323
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
||
|
WHO-ATC |
M02AA16
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
||
|
WHO-VATC |
QM01AX18
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
||
|
WHO-VATC |
QM01AX68
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
||
|
WHO-VATC |
QM02AA16
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
||
|
WHO-ATC |
M01AX68
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB13364
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
D011298
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
8673
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000080977
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
Feprazone
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
m5309
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | Merck Index | ||
|
35455
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
250-324-3
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
7BVX6J0CGR
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
SUB07607MIG
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
DTXSID3023051
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
30748-29-9
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
C65675
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
3441
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
CHEMBL1452696
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY | |||
|
1169
Created by
admin on Fri Dec 15 16:36:55 GMT 2023 , Edited by admin on Fri Dec 15 16:36:55 GMT 2023
|
PRIMARY |
ACTIVE MOIETY